Supplementary Table S5 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer

<p>Differentially methylated CpG sites in HER3+ vs HER3- breast cancer samples (TNBC cohort)</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Erwin Tomasich (15052256) (author)
Autres auteurs:	Ariane Steindl (15022655) (author), Christina Paiato (15360180) (author), Teresa Hatziioannou (15052262) (author), Markus Kleinberger (15360183) (author), Luzia Berchtold (15360186) (author), Rainer Puhr (15052253) (author), Johannes A. Hainfellner (15360189) (author), Leonhard Müllauer (15118769) (author), Georg Widhalm (15052268) (author), Franziska Eckert (15360192) (author), Rupert Bartsch (15360195) (author), Gerwin Heller (15052250) (author), Matthias Preusser (15017558) (author), Anna Sophie Berghoff (15360198) (author)
Publié:	2025
Sujets:	Cancer Tumor Biology Therapeutic Research and Development Clinical Research and Trials Biological Agents & Therapies Antibody-drug conjugates Breast Cancer Clinical-Stage Research Drug Targets Cell surface receptor drug targets Lung Cancer Progression, Invasion & Metastasis Metastasis
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires